Related Experiment Video
Updated: May 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Challenges in atrial fibrillation
Ron Pisters1, Hugo Ten Cate, Harry J Crijns
1Department of Cardiolog, Maastricht University Medical Centre, Maastricht, The Netherlands. r.pisters@mumc.nl
Managing atrial fibrillation (AF) requires careful antithrombotic therapy. This review focuses on antiplatelet agents, stroke, and bleeding risk assessment in AF patients.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a common chronic heart condition.
- Managing AF is complex due to associated heart diseases.
- Antithrombotic therapy in AF presents significant challenges.
Purpose of the Study:
- To review the current use of antiplatelet agents in AF management.
- To address challenges in assessing stroke and bleeding risks.
- To explore novel antithrombotic agents for future AF treatment.
Main Methods:
- Literature review of current guidelines and clinical tools.
- Analysis of antiplatelet agent efficacy and safety in AF.
- Discussion of risk stratification models for stroke and bleeding.
- Exploration of emerging antithrombotic therapies.
Main Results:
- Current antiplatelet strategies require careful risk-benefit assessment.
- Clinical tools exist for evaluating stroke and bleeding risks.
- Novel agents may offer improved antithrombotic management in AF.
Conclusions:
- Optimizing antithrombotic therapy in AF is crucial.
- Accurate risk assessment is key for antiplatelet agent selection.
- Future research should focus on personalized antithrombotic approaches in AF.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias

